Iridex regains Nasdaq listing compliance

*
Ophthalmic medical technology company, Iridex (NASDAQ:IRIX [https://seekingalpha.com/symbol/IRIX]) on Tuesday said that it has received formal notice from Nasdaq confirming it has regained compliance with continued listing standards.

*
The company had previously received a non-compliance notice on May 14, 2025, related to stockholders’ equity requirements under Nasdaq Listing Rule 5550(b).

*
The exchange confirmed Iridex met the $2.5 million minimum stockholders’ equity requirement based on its Q2 report filed on August 12, 2025. The matter is now closed.

* IRIX -2.2% after hours to $1.33.
* Source: Press Release [https://seekingalpha.com/pr/20227021-iridex-corporation-receives-formal-notification-of-nasdaq-listing-compliance]

MORE ON IRIDEX

* IRIDEX Corporation (IRIX) Q2 2025 Earnings Call Transcript [https://seekingalpha.com/article/4812879-iridex-corporation-irix-q2-2025-earnings-call-transcript]
* Iridex outlines further cost reductions and targets profitability in 2025 as Q2 revenue rises 14% sequentially [https://seekingalpha.com/news/4484371-iridex-outlines-further-cost-reductions-and-targets-profitability-in-2025-as-q2-revenue-rises]
* Financial information for IRIDEX [https://seekingalpha.com/symbol/IRIX/income-statement]